Streptococcus pneumoniae vaccine (Cytovax Biotechnologies)

肺炎链球菌疫苗 (Cytovax Biotechnologies)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStreptococcus pneumoniae vaccine (Cytovax Biotechnologies)

Drug Alias NameS pneumoniae vaccine

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCytovax Biotechnologies

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCytovax Biotechnologies

Active IndicationsN/A

Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A